The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care model.
- DOI
- 10.1007/s00277-026-07290-9
- Published
- 2026 Sep 26
- Container
- Annals of hematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00277-026-07290-9,
title = {The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care model.},
author = {Schneider MMK and Müller G and Herbst S and Slesaczeck J and Schmädig R and Schmidt F and Illmer T and Leppla L and Valenta S and De Geest S and Teynor A and Wolfien M and Ernst A and Bischof L and Schmitt J and Hänel M and Metzeler KH and Platzbecker U and Vučinić V and Schetelig J and Bornhäuser M and Middeke JM and Egger-Heidrich K},
year = {2026},
journal = {Annals of hematology},
doi = {10.1007/s00277-026-07290-9},
url = {https://doi.org/10.1007/s00277-026-07290-9}
}RIS
TY - JOUR TI - The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care model. AU - Schneider MMK AU - Müller G AU - Herbst S AU - Slesaczeck J AU - Schmädig R AU - Schmidt F AU - Illmer T AU - Leppla L AU - Valenta S AU - De Geest S AU - Teynor A AU - Wolfien M AU - Ernst A AU - Bischof L AU - Schmitt J AU - Hänel M AU - Metzeler KH AU - Platzbecker U AU - Vučinić V AU - Schetelig J AU - Bornhäuser M AU - Middeke JM AU - Egger-Heidrich K PY - 2026 JO - Annals of hematology DO - 10.1007/s00277-026-07290-9 UR - https://doi.org/10.1007/s00277-026-07290-9 ER -
APA
MMK, S., G, M., S, H., J, S., R, S., F, S., T, I., L, L., S, V., S, D. G., A, T., M, W., A, E., L, B., J, S., M, H., KH, M., U, P., V, V., J, S., M, B., JM, M., & K, E. (2026). The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care model.. Annals of hematology. https://doi.org/10.1007/s00277-026-07290-9
Source records
- pubmed · retrieved 2026-09-27T10:44:24.021Z